Abstract
A randomised, double blind, placebo controlled trial of nedocromil sodium was undertaken to assess its corticosteroid sparing effect in 50 adults with asthma who had required an oral corticosteroid dose of (or equivalent to) at least 5 mg prednisolone a day continuously during the preceding year, in addition to inhaled beclomethasone dipropionate and bronchodilators. Patients having corticosteroids other than prednisolone were changed to prednisolone. A four week baseline period was followed by 20 weeks of inhaled nedocromil sodium (16 mg daily) or placebo. After four weeks of the treatment phase an attempt was made to reduce the oral prednisolone maintenance dose by 2.5 mg a fortnight until a dose of 5 mg daily was reached and thereafter by 1 mg a fortnight, provided that there was no significant clinical deterioration as judged by clinic assessments and daily diary cards. Of 50 patients recruited, 47 entered the treatment phase (age range 16-64 years), 24 receiving nedocromil sodium and 23 placebo. The total steroid reduction achieved was 2.5 mg in the nedocromil group and 3 mg in the placebo group, which did not differ significantly. There was no significant change in symptoms, lung function or inhaler use in either group during the study. The number of patient requiring short term upward adjustment of booster doses of oral prednisolone for exacerbations of asthma was similar in the two groups (26 with placebo, 28 with nedocromil). Thus nedocromil sodium does not appear to provide an oral corticosteroid sparing effect in chronic steroid dependent asthma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dixon C. M., Fuller R. W., Barnes P. J. Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax. 1987 Jun;42(6):462–465. doi: 10.1136/thx.42.6.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dorward A. J., Roberts J. A., Thomson N. C. Effect of nedocromil sodium on histamine airway responsiveness in grass-pollen sensitive asthmatics during the pollen season. Clin Allergy. 1986 Jul;16(4):309–315. doi: 10.1111/j.1365-2222.1986.tb01962.x. [DOI] [PubMed] [Google Scholar]
- Fyans P. G., Chatterjee P. C., Chatterjee S. S. A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma. Clin Allergy. 1986 Nov;16(6):505–511. doi: 10.1111/j.1365-2222.1986.tb01988.x. [DOI] [PubMed] [Google Scholar]
- Juniper E. F., Kline P. A., Morris M. M., Hargreave F. E. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate. Clin Allergy. 1987 Nov;17(6):523–528. doi: 10.1111/j.1365-2222.1987.tb02048.x. [DOI] [PubMed] [Google Scholar]
- Lal S., Malhotra S., Gribben D., Hodder D. Nedocromil sodium: a new drug for the management of bronchial asthma. Thorax. 1984 Nov;39(11):809–812. doi: 10.1136/thx.39.11.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts J. A., Thomson N. C. Attenuation of exercise-induced asthma by pretreatment with nedocromil sodium and minocromil. Clin Allergy. 1985 Jul;15(4):377–381. doi: 10.1111/j.1365-2222.1985.tb03006.x. [DOI] [PubMed] [Google Scholar]
- Robuschi M., Vaghi A., Simone P., Bianco S. Prevention of fog-induced bronchospasm by nedocromil sodium. Clin Allergy. 1987 Jan;17(1):69–74. doi: 10.1111/j.1365-2222.1987.tb02321.x. [DOI] [PubMed] [Google Scholar]
- Shaw R. J., Kay A. B. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. Br J Dis Chest. 1985 Oct;79(4):385–389. doi: 10.1016/0007-0971(85)90073-7. [DOI] [PubMed] [Google Scholar]
- Youngchaiyud P., Lee T. B. Effect of nedocromil sodium on the immediate response to antigen challenge in asthmatic patients. Clin Allergy. 1986 Mar;16(2):129–134. doi: 10.1111/j.1365-2222.1986.tb00756.x. [DOI] [PubMed] [Google Scholar]